Athanassios Argiris
Papers
1
Total Citations
13
H-Index
1
About
Dr. Athanassios Argiris is a leading clinical investigator in head and neck oncology, with a primary focus on the intersection of immunotherapy and surgical outcomes for head and neck squamous cell carcinoma (HNSCC). His most cited work, a 2023 study on the effect of preoperative PD-1/PD-L1 immune checkpoint inhibition, provides critical data on post-surgical complication rates in patients receiving neoadjuvant immunotherapy. This research addresses a significant gap in the literature, offering evidence-based insights that directly inform clinical decision-making for patients undergoing surgery for primary HNSCC. With 13 citations, this paper has already shaped discussions on the safety and feasibility of combining immune checkpoint inhibitors with surgical resection. Dr. Argiris’s contributions are vital for advancing personalized, multimodal treatment strategies, helping to optimize both oncologic outcomes and surgical recovery in this challenging patient population.
Research Focus
Key Achievements
Top Papers
- 1